Special Issue "Fish Gelatins: Their Production, Functional Properties, and Nutraceutical Applications"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: 31 December 2018
Prof. Dr. Chun-Yung Huang
Gelatin is a polypeptide derived by partial hydrolysis of collagen, the principle fibrous protein constituent in the bones, cartilages and skin of animal. Insoluble native collagen must be pre-treated before it can be converted into a form suitable for extraction; this pre-treatment is normally accomplished by heating in water and the heat cleaving the hydrogen and covalent bonds to destabilize the triple-helix, resulting in helix-to-coil transition and conversion into soluble gelatin. Gelatin is traditionally extracted from the skin and bone collagen of certain mammalian species, primarily cows and pigs. However, gelatin production from alternative non-mammalian species has grown in importance due to religious sentiments and safety considerations, especially bovine spongiform encephalopathy (BSE) and foot-and-mouth disease virus (FMDV). These socio-cultural and safety concerns have led to rigorous research to identify and develop alternatives to mammal-derived gelatin.
The classical application of gelatin in food, photographic, cosmetic and pharmaceutical industry is based mainly on its gel-forming and viscoelastic properties. Recently, a variety of new applications of gelatin have been found in emulsifiers, foaming agents, colloid stabilizers, fining agents, biodegradable packaging materials and micro-encapsulating agents. In this Special Issue “Fish Gelatins: Their Production, Functional Properties, and Nutraceutical Applications” of Marine Drugs will cover the whole scope of production, functional properties, and nutraceutical applications of fish gelatin. This Special Issue is focused on (but not limited to) nutraceutical and therapeutic applications of fish gelatin including gelatin hydrolysate with biological activities, gelatin peptides and proteins, nutraceutical delivery systems, gelatin nanoparticles, micro-encapsulating agents, and complementary therapeutic effects.
We look forward to your input.
Prof. Dr. Chun-Yung Huang
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- biological functions
- complementary therapeutic effects
- drug delivery systems
- extraction method
- fish gelatin
- gelatin hydrolysate
- gelatin peptides
- micro-encapsulating agents